🍽🦠 PubMed Studies Citing Bacteria Shifts for Ganoderma sichuanense {Reishi Mushroom} - Prevotella intermedia

Citations are updated once a week. Recently added citations may not appear.

3 Citations Found, Full List Requires Login Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
πŸ““ - Direct Citation   |   πŸ‘ͺ - Infer Parent  |   πŸ‘Ά - Infer Child |   βš—οΈ - Inferred from bacteria association
For Samples: 😁 - Shifts in right direction   |   😒 - Shifts in wrong direction
Context Citation
Ganoderma sichuanense {Reishi Mushroom} - Prevotella intermedia    👶 Polysaccharides of Sporoderm-Broken Spore of Ganoderma lucidum Modulate Adaptive Immune Function via Gut Microbiota Regulation.
Evidence-based complementary and alternative medicine : eCAM (Evid Based Complement Alternat Med ) Vol: 2021 Issue Pages: 8842062
Pub: 2021 Epub: 2021 Mar 23 Authors Su L , Li D , Su J , Zhang E , Chen S , Zheng C , Luo T , Li M , Chen X , Huang G , Xie Y , Li S ,
Html Article Publication
Ganoderma sichuanense {Reishi Mushroom} - Prevotella intermedia    👶 Regulatory effect of Ganoderma lucidum and its active components on gut flora in diseases.
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1362479
Pub: 2024 Epub: 2024 Mar 18 Authors Qin X , Fang Z , Zhang J , Zhao W , Zheng N , Wang X ,
Html Article Publication
Ganoderma sichuanense {Reishi Mushroom} - Prevotella intermedia    👶 Effects of Mexican Ganoderma lucidum extracts on liver, kidney, and the gut microbiota of Wistar rats: A repeated dose oral toxicity study.
PloS one (PLoS One ) Vol: 18 Issue 4 Pages: e0283605
Pub: 2023 Epub: 2023 Apr 6 Authors Meneses ME , Martínez-Carrera D , González-Ibáñez L , Torres N , Sánchez-Tapia M , Márquez-Mota CC , Rendón G , Mitzi V , Morales A , Tello-Salgado I , Tovar AR ,
Html Article Publication

BOOM

All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.

Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)